Protein Characterization & Identification Market Revenue to Attain USD 7.63 Bn by 2033

08 Sep 2025

Share :

Table of Content

1. Protein Characterization & Identification Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Boosting the Growth of the Protein Characterization & Identification Market? 3. Segment Insights 4. Protein Characterization & Identification Market Coverage 5. Protein Characterization & Identification Market Key Players

Protein Characterization & Identification Market Revenue and Trends 2025 to 2033

The global protein characterization & identification market revenue reached USD 5.05 billion in 2025 and is predicted to attain around USD 7.63 billion by 2033 with a CAGR of 5.29%. The market is expanding due to increasing biopharmaceutical R&D, growing demand for personalized medicine, and advancements in proteomics.

What are the Key Factors Boosting the Growth of the Protein Characterization & Identification Market?

The protein characterization & identification market is witnessing robust growth, driven by the rising demand for high-end biologics, advanced biopharmaceuticals, and vaccines, along with the increasing prevalence of chronic diseases and cancer, all of which require precise protein analysis technologies. With increased investment in proteomics research, advances in protein analysis technologies, including those utilizing mass spectrometry, chromatography, and electrophoresis, are making protein analysis easier, more efficient, and more accurate, thereby boosting market adoption. Furthermore, strict regulations on naturally sourced biologics and increased pharmaceutical R&D investments globally are pushing companies to adopt protein characterization techniques for product differentiation. These factors collectively position the market for future growth.

Segment Insights

• By Product/offering, the instruments & systems segment led the market in 2024. This is mainly due to the growing demand for advanced analytical tools that offer high accuracy, sensitivity, and throughput.
• By Technology/method, the mass spectrometry (LC-MS/MS, MALDI-TOF, HR-MS) segment dominated the market in 2024, primarily due to its widespread adoption, which enables the high-throughput identification and analysis of proteins. The segment dominance is also attributed to its high sensitivity, accuracy, and ability to analyze complex protein mixtures rapidly.
• By Workflow stage / use case, the protein identification & sequencing segment continues to dominate the market, owing to its high accuracy and efficiency in protein analysis. It also serves as the foundational step in understanding protein structure and function.
• By Sample type, the recombinant/biotherapeutic proteins (mAbs, ADCs) segment led the market in 2024 due to the rapid growth of biologics in the pharmaceutical industry. Monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) require detailed characterization to ensure efficacy, safety, and compliance with regulatory requirements.
• By End-user, the biopharmaceutical & CROs segment contributed the largest market share in 2024 due to their critical role in developing and manufacturing biologics, including monoclonal antibodies and vaccines.

Regional Insights

North America registered dominance in the protein characterization & identification market by holding the largest share in 2024. This is mainly due to its focus on biopharmaceutical research, well-developed healthcare sector, and high R&D investments. The presence of major market players and strict regulations for biologics safety and efficacy further drive the adoption of advanced protein analysis methods in the region.

Asia Pacific is expected to expand at the fastest rate during the forecast period, driven by increased pharmaceutical manufacturing, biopharmaceutical R&D, and healthcare infrastructure. Continued government support for R&D, favorable investment policies in biotech, and the rising use of contract research organizations (CROs) will further fuel market growth in the region. Rising healthcare spending also influences the market growth.

Protein Characterization & Identification Market Coverage

Recent Development

• On September 3, 2025, Illumina Inc. launched Illumina Protein Prep, a high-performance assay for NGS-based proteomics, which is now available globally following an early-access release. It enables researchers to integrate proteomics into large-scale genomics studies, driving new insights into cancer, cardiometabolic, and immunologic diseases with a streamlined sample-to-insights workflow. (Source: https://www.illumina.com)

Protein Characterization & Identification Market Key Players

• Thermo Fisher Scientific
• Agilent Technologies
• Waters Corporation
• Bruker Corporation
• SCIEX (Danaher group)
• Shimadzu Corporation
• Merck KGaA / MilliporeSigma
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• Cytiva (GE Life Sciences alumni)
• Promega Corporation
• Bio-Techne Corporation
• Eurofins Scientific (proteomics & testing services)
• Charles River Laboratories (analytical & bioanalytical services)
• NanoTemper Technologies

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6728

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344